AKM DIMETHYL FUMARATE, FURATEC, PHARMACOR DIMETHYL FUMARATE (Pharmacor Pty Ltd)
Product name
AKM DIMETHYL FUMARATE, FURATEC, PHARMACOR DIMETHYL FUMARATE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
177 (255 working days)
Active ingredients
dimethyl fumarate
Registration type
New generic medicine
Indication
AKM DIMETHYL FUMARATE, FURATEC, PHARMACOR DIMETHYL FUMARATE (delayed release capsule) is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.